Preoperative sentinel node identification with ultrasound using microbubbles in patients with breast cancer

American Journal of Roentgenology

Volumn 196, Issue 2, 2011, Pages 251-256

  Sever, Ali R ^a   Mills, Philippa ^a   Jones, Susan E ^a   Cox, Karina ^a   Weeks, Jennifer ^a   Fish, David ^a   Jones, Peter A ^a  

^a MAIDSTONE HOSPITAL   (United Kingdom)

Author keywords

Breast cancer; Contrast enhanced ultrasound; Microbubble contrast agents; Preoperative staging; Sentinel lymph node

Indexed keywords

NANOCOLL TC 99M; SONOVUE;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SURGERY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; GUIDE WIRE; HISTOPATHOLOGY; HUMAN; INJECTION SITE BURNING; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROBUBBLE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; CARCINOMA IN SITU; CARCINOMA, DUCTAL; CARCINOMA, LOBULAR; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MAMMOGRAPHY; MICROBUBBLES; MIDDLE AGED; PHOSPHOLIPIDS; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, MAMMARY;

EID: 79251509907     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4865     Document Type: Article

References (35)

1. Fisher B, Bauer M, Wickerham D, Redmond CK, Fisher ER. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 1983; 52:1551-1557 (Pubitemid 13018271)
2. Carter CL, Allen C, Henderson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989; 63:181-187 (Pubitemid 19032001)
3. Cady B, Stone MD, Schuler JG, Thakur R, Wan ner MA, Lavin PT. The new era in breast cancer: invasion, size, and nodal involvement dramatically decreasing as a result of mammographic screening. Arch Surg 1996; 131:301-308 (Pubitemid 26078817)
4. Silverstein MJ, Skinner KA, Lomis TJ. Predicting axillary nodal positivity in 2282 patients with breast carcinoma. World J Surg 2001; 25:767-772
5. Schrenk P, Rieger R, Shamiyeh A, Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 2000; 88:608-614
6. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 2003; 29:341-350
7. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127:392-399
8. Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-398
9. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-340
10. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-1822
11. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23:7703-7720
12. Kim T, Giuliano AE, Lyman GH. Lymphatic mapping and sentinel lymph node sampling in early stage breast cancer: a meta-analysis. Cancer 2006; 106:4-16
13. De Freitas R, Costa MV, Schneider SV, et al. Accuracy of ultrasound and clinical examination in the diagnosis of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 1991; 17:240-244
14. Nori J, Vanzi E, Bazzocchi M, et al. Role of axillary ultrasound examination in the selection of breast cancer patients for sentinel node biopsy. Am J Surg 2007; 193:16-20 (Pubitemid 44937150)
15. Alvarez S, Añorbe E, Alcorta P, López F, Alonso I, Cortés J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR 2006; 186:1342-1348
16. Cosgrove D. Ultrasound contrast agents: an overview. Eur J Radiol 2006; 60:324-330
17. Goldberg BB, Merton DA, Liu JB, et al. Sentinel lymph nodes in a swine model with melanoma: contrast-enhanced lymphatic US. Radiology 2004; 230:727-734 (Pubitemid 38252870)
18. Sever A, Jones S, Cox K, Weeks J, Mills P, Jones P. Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer. Br J Surg 2009; 96:1295-1299
19. Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? AJR 2009; 193:55-60
20. Piscaglia F, Bolondi L. The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol 2006; 32:1369-1375 (Pubitemid 44332662)
21. Correas JM, Bridal L, Lesavre A, et al. Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts. Eur Radiol 2001; 11:1316-1328 (Pubitemid 32755614)
22. Mustonen P, Farin P, Kosunen O. Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Ann Chir Gynaecol 1990; 79:15-18
23. Britton PD, Provenzano E, Barter S, et al. Ultrasound guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied? Breast 2009; 18:13-16
24. Goldfarb LR, Alazraki NP, Eshima D, Eshima LA, Herda SC, Halkar RK. Lymphoscintigraphic identification of sentinel lymph nodes: clinical evaluation of 0.22-micron filtration of Tc-99m sulphur colloid. Radiology 1998; 208:505-509
25. Camp ER, Cendan JC, Feezor R, Lind DS, Wilkinson E, Copeland EM. The hottest sentinel lymph node is not always the positive node. Am Surg 2004; 70:475-478
26. Liu LC, Lang JE, Jenkins T, et al. Is it necessary to harvest additional lymph nodes after resection of the most radioactive sentinel lymph node in breast cancer? J Am Coll Surg 2008; 207:853-858
27. Bourgeois P, Nogaret JM, Veys I, et al. How "hot" is the pathologically positive sentinel lymph node in breast cancer patients? Nucl Med Commun 2003; 24:513-518
28. Govaert GAM, Oostenbroek RJ, Plaisier PW. Prolonged skin staining after intradermal use of patent blue in sentinel lymph node biopsy for breast cancer. Eur J Surg Oncol 2005; 31:373-375
29. Scherer K, Studer W, Figueiredo V, Bircher AJ. Anaphylaxis to isosulphan blue and cross-reactivity to patent blue V: case report and review of the nomenclature of vital blue dyes. Ann Allergy Asthma Immunol 2006; 96:497-500
30. Veronesi U, Paganelli G, Viale G, et al. A randomised comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349:546-553
31. Intra M, Rotmensz N, Veronesi P, et al. Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years. Ann Surg 2008; 247:315-319
32. Van la Parra RF, Ernst MF, Barneveld PC, Broekman JM, Rutten MJ, Bosscha K. The value of sentinel lymph node biopsy in ductal carcinoma in situ (DCIS) and DCIS with microinvasion of the breast. Eur J Surg Oncol 2008; 34:631-635
33. Boughey JC, Khakpour N, Meric-Bernstam F, et al. Selective use of sentinel lymph node surgery during prophylactic mastectomy. Cancer 2006; 107:1440-1447
34. Papa MZ, Zippel D, Kaufman B, et al. Timing of sentinel lymph node biopsy in patients receiving neoadjuvant chemotherapy for breast cancer. J Surg Oncol 2008; 98:403-406
35. Schrenk P, Tausch C, Wölfl S, Bogner S, Fridrik M, Wayand W. Sentinel node mapping performed before preoperative chemotherapy may avoid axillary dissection in breast cancer patients with negative or micrometastatic sentinel nodes. Am J Surg 2008; 196:176-183